¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"rate ratio"¿¡ ´ëÇÑ °Ë»ö °á°úÀÔ´Ï´Ù. °Ë»ö °á°ú º¸´Â µµÁß¿¡ Tab ۸¦ ´©¸£½Ã¸é °Ë»ö âÀÌ ¼±Åõ˴ϴÙ.
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
  • monocyte lymphocyte ratio
    ´ÜÇÙ±¸¸²ÇÁ±¸ºñÀ²
  • mortality ratio
    »ç¸Áºñ
  • marriage-divorce ratio
    °áÈ¥ÀÌÈ¥ºñ
  • mendelian ratio
    ¸àµ¨ºñÀ²
  • magnetization transfer ratio
    ÀÚ±âÈ­Àü´ÞºñÀ²
  • noise ratio
    ÀâÀ½ºñ
  • nuclear-cytoplasmic ratio
    ÇÙ¼¼Æ÷Áúºñ
  • odds ratio
    ±³Â÷ºñ, ½Â»êºñ
  • optimal proportion ratio
    ÃÖÀûºñ
  • optimal ratio
    ÃÖÀûºñ
  • oxygen enhancement ratio
    »ê¼ÒÈ¿°úÁõ°­·ü, »ê¼ÒÁõ°­ºñ
  • phase ratio
    »óºñ
  • primary sex ratio
    ÀÏÂ÷¼ººñ
  • ratio
    1. ºñ 2. ºñÀ², À²
  • ratio scale
    ºñÀ²Ã´µµ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 4 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
  • response rate
    ¹ÝÀÀ·ü
  • standardized death rate
    Ç¥ÁØÈ­»ç¸Á·ü
  • survival rate
    »ýÁ¸·ü
  • tidal rate
    È£Èí¼ö
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
  • intelligence qoutient ratio
    Áö´ÉºñÀ²Áö¼ö
  • International Normalized ratio
    ±¹Á¦Á¤»óÈ­ºñÀ²
  • inverse-ratio ventilation
    ¿ªºñȯ±â
  • ketogenic antiketogenic ratio
    ÄÉÅæÇ×ÄÉÅæºñÀ²
  • magnetization transfer ratio
    ÀÚ±âÈ­Àü´ÞºñÀ²
  • marriage-divorce ratio
    °áÈ¥ÀÌÈ¥À²
  • mendelian ratio
    ¸àµ¨·ü
  • mixing water ratio
    ¹°È¥ÇÕºñ
  • monocyte lymphocyte ratio
    ´ÜÇÙ±¸¸²ÇÁ±¸ºñÀ²
  • mortality ratio
    »ç¸Áºñ
  • noise ratio
    ÀâÀ½ºñ
  • nuclear-cytoplasmic ratio
    ÇÙ¼¼Æ÷Áúºñ
  • odds ratio
    ±³Â÷ºñ
  • optimal ratio
    ÃÖÀûºñ
  • optimal proportion ratio
    (¢¡optimal ratio) ÃÖÀûºñ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
  • actual death rate
    ½ÇÁ¦»ç¸Á·ü(ËàÌ¡Ë×ËÎËô).
  • adjusted death rate
    Á¶Á¤»ç¸Á·ü.
  • age specific death rate
    ¿¬·Éº° »ç¸Á·ü
  • air kerma-rate constant
    °ø±âÄ¿¸¶À²»ó¼ö
  • alveolar ventilation rate
    ÆóÆ÷ȯ±âºñ(¡­üµÑ¨Ýï)
  • arterial perfusion rate
    µ¿¸Æ°ü·ùÀ²
  • fractional fibrinogen catabolic rate
    ºÐȹº° ¼¶À¯¼Ò¿ø ´ë»çÀ².
  • frame rate
    È­¸éÀ²
  • frame rate
    È­¸é ¹ß»ýÀ² (ûþØü Û¡ßæëÒ)
  • general fertility rate
    ÀϹÝÃâ»êÀ².
  • general fertility rate
    ÀϹÝÃâ»êÀ².
  • glomerular filtration rate
    »ç±¸Ã¼ ¿©°úÀ²
  • glomerular filtration rate
    »ç±¸Ã¼¿©°úÀ²
  • glomerular filtration rate =GFR
    »ç±¸Ã¼¿©°úÀ²(¡­ÕëΦëÏ).
  • glomerular filtration rate =GFR
    »ç±¸Ã¼¿©°úÀ².
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
  • marriage-divorce ratio
    °áÈ¥-ÀÌÈ¥À²(Ë­Ì´ËöÌ´Ëô).
  • mendelian ratio
    ¸àµ¨·ü(¡­ëÏ).
  • mendelian ratio
    ¸àµ¨·ü(¡­ëÏ)
  • mixing water ratio
    È¥¼öºñ(ûèâ©Ýï) ¡ì¼®°í¡í.
  • monocyte lymphocyte ratio
    ´Ü±¸¸²ÇÁ±¸ºñ(ӤϹ¡­Ï¹Ýï).
  • monocyte lymphocyte ratio
    ´Ü±¸¸²ÇÁ±¸ºñ(ËÀË´?Ë´ËÓ).
  • noise ratio
    ÀâÀ½ºñ(ËöËôËÓ).
  • noise ratio
    ÀâÀ½ºñ
  • optimal proportion =o. ratio
    ÃÖÀûºñ (Ì§ËøËÓ).
  • optimal ratio
    ÃÖÀûºñ.
  • optimum ratio
    ÃÖÀûºñ
  • optimum ratio
    ÃÖÀûºñ(õÌîêÝï).
  • oxygen enhancement ratio (OER)
    »ê¼ÒÁõ°­ºñ
  • oxygen enhancement ratio =OER
    »ê¼ÒÈ¿°úÁõ°­·ü(¡­üùÍýñòË­ëÒ).
  • phase ratio
    »óºñ(ßÓÝï).
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
  • P:O ratio
    P/O ºñ
  • protein efficiency ratio
    ´Ü¹éÁú(Ó±ÛÜòõ) È¿À²ºñ(üù×ËÝï)
  • protein efficiency ratio method
    ´Ü¹éÁú(Ó±ÛÜòõ) È¿À²ºñ¹ý(üù×ËÝïÛö)
  • signal-to-noise ratio
    ½ÅÈ£/ÀâÀ½ºñ(ãáûÜ/íÚëåÝï)
  • viscosity ratio
    Á¡µµÀ²(ïÄÓøëÒ)
KMLE ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 4
ACR abnormally contracting region; absolute catabolic rate; acriflavine; adenomatosis of colon and rectu...
A/G ratio Albumin/Globulin ratio; ¾ËºÎ¹Î´ë ±Û·ÎºÒ¸°ÀÇ ºñÀ²
S/D ratio Systolic / Diastolic ratio
C/N carbon/nitrogen [ratio]; carrier/ noise [ratio]
DR degeneration reaction; delivery room; deoxyribose; diabetic retinopathy; diagnostic radiology; digit...
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 4
DAR Differential absorption ratio
ER Enhancement Ratio
FCR Feed conversion ratio
FR Fixed Ratio
FR1 Fixed Ratio 1
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
  • erythrocyte sedimentation rate
    ÀûÇ÷±¸ ħ°­ ¼Óµµ
    ÀÀ°íµÇÁö ¾ÊÀº Ç÷¾×À» ´ãÀº °ü¿¡¼­ ÀûÇ÷±¸°¡ °¡¶ó¾É´Â À²·Î¼­ ½Ã°£´ç mm·Î Ç¥½ÃÇÑ´Ù. ÀûÇ÷±¸ ħ°­ ¼ÓµµÀÇ Áõ°¡´Â ¿°ÁõÀÌ ÀÖ´Ù´Â °ÍÀ» ÀǹÌÇϳª Ưº°ÇÑ Àå¾Ö¿¡ ´ëÇØ °íÀ¯ÇÏÁö´Â ¾Ê´Ù.
  • fertility rate
    Ãâ»êÀ², ¼öÁ¤·ü
  • fractional fibrinogen catab rate
    ºÐȹº° ¼¶À¯¼Ò¿ø ´ë»çÀ²
  • heart rate meter
    ½É¹Ú°è, ½ÉÀå ¹Úµ¿°è, ½É¹Úµ¿°è
  • hebdomadal death rate
    »ýÈÄ ÀÏ ÁÖ°£ »ç¸Á·ü
  • high repitition rate
    °í¹Ýº¹À², ³ôÀº ¹Ýº¹À²
  • incidence rate
    ¹ßº´À², ¹ß»ý·ü
    ¾î´À ÁúȯÀÇ ¹ß»ýÀÌ ÀÏÁ¤ Áö¿ª, ÀÏÁ¤ ±â°£¿¡ ÇÑÁ¤µÇ¾î ÀÖÀ» ¶§ÀÇ ÀÌȯÀ²À» ¸»ÇÑ´Ù. ¿¹¸¦ µé¸é È«¿ª°ú °°Àº ±Þ¼º Àü¿°º´ÀÇ °æ¿ì³ª À¯¹® ÇùÂøÁõ°ú °°Àº Ãâ»ý ÈÄ¿¡¸¸ ÀϾ´Â Áúº´ µîÀÇ °æ¿ìÀÌ´Ù. ÀÌµé °æ¿ì¿¡´Â ¹ßº´ÀÇ À§Çè¿¡ ³ëÃâµÇ¾î ÀÖ´Â Àα¸°¡ ÇÑÁ¤µÇ¾î Àֱ⠶§¹®¿¡ ¹ß»ý ȯÀÚ ¼ö¸¦ ±× Àα¸·Î ³ª´©¾î¼­ ¹ßº´·üÀ» ±¸ÇÒ ¼ö ÀÖ´Ù.
  • maternal death rate
    ¸ð¼º »ç¸Á·ü
  • maternal mortality rate
    ¸ð¼º »ç¸Á·ü, ÀÓ»êºÎ »ç¸Á·ü
  • maximum expiratory flow rate
    ÃÖ´ë È£±â À¯·®·ü
  • maximum mid-expiratory flow rate
    ÃÖ´ë Áß°£ È£±â À¯Ãâ ¼Óµµ
  • mean airflow rate
    ¹ß¼º½Ã È£±â·ùÀ²
  • metabolic rate
    ´ë»çÀ²
  • mortality rate
    »ç¸Á·ü
  • mutation rate
    º¯ÀÌÀ², µ¹¿¬º¯ÀÌÀ²
CancerWEB ¿µ¿µ ÀÇÇлçÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 4
odds ratio <epidemiology> A comparison of the presence of a risk factor for disease in a sample of diseased subjects and non diseased controls. The number of people with disease who were exposed to a risk factor ( I.e. ) over those with disease who were not exposed ( Io ) divided by those without disease who were exposed ( Ne ) over those without who were not exposed ( No ). Thus OR=(I.e./Io)/(Ne/No)= I.e. No / Io Ne. This measure should be used for case control studies where we retrospectively look at risks in those with and without disease. Also known as exposure odds ratio.
(05 Dec 1998)
therapeutic ratio The ratio of the maximally tolerated dose of a drug to the minimal curative or effective dose; LD50 divided by ED50.
(05 Mar 2000)
tritium-breeding ratio <radiobiology> The amount of tritium generated by the breeding blanket of a D-T fusion reactor, divided by the amount of tritium burned in the reactor. A tritium breeding ration greater than unity is necessary for self-sufficient fueling.
(09 Oct 1997)
turn down ratio The lowest load at which a boiler will operate efficiently as compared to the boiler's maximum design load.
(05 Dec 1998)
exposure odds ratio <epidemiology> See Odds ratio.
(05 Dec 1998)
extraction ratio The fraction of a substance removed from the blood flowing through the kidney; it is calculated from the formula (A -V)/A, where A and V, respectively, are the concentrations of the substance in arterial and renal venous plasma.
(05 Mar 2000)
K:A ratio <abbreviation> Ketogenic-antiketogenic ratio.
(05 Mar 2000)
ketogenic-antiketogenic ratio The proportion between substances that form ketones in the body and those that form d-glucose.
(05 Mar 2000)
zeta sedimentation ratio The ratio of the zetacrit to the haematocrit, normally 0.41 to 0.54 (41 to 54%); it is a sensitive indicator of the erythrocyte sedimentation rate (ESR) and, unlike the latter, is unaffected by anaemia, which tends to elevate the ESR.
(05 Mar 2000)
fertility ratio A measure of the fertility of a population based on the female population in the child-bearing age-group, defined as ages 15-49 years.
(05 Mar 2000)
flux ratio The ratio of the two unidirectional fluxes through a particular boundary layer or membrane.
(05 Mar 2000)
lecithin/sphingomyelin ratio A ratio used to determine foetal pulmonary maturity, found by testing the amniotic fluid; when the lungs are mature, lecithin exceeds sphingomyelin by 2 to 1.
(05 Mar 2000)
functional terminal innervation ratio The number of muscle fibres divided by the number of axons that innervate them.
(05 Mar 2000)
low aspect ratio <physics> An aspect ratio for a torus that is small (minor radius is almost as big as major radius).
There are many fusion devices which are designed to have a low aspect ratio. Such devices look more like tractor tires than bicycle tires, as toruses go. There are reasons to believe that low aspect ratio devices will offer some advantages for a fusion reactor. Usually, ease of theoretical and/or numerical analysis is not one of these advantages.
(16 Mar 1998)
L/S ratio <abbreviation> Lecithin/sphingomyelin ratio.
(05 Mar 2000)
ÇÑ¿µ/¿µÇÑ »çÀü À¯»ç °Ë»ö °á°ú : 14 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
  • interest rate
    ±Ý¸®ÀÌÀ²
  • kill rate
    (ÀüÀï,Æøµ¿ µîÀÇ)»ì»ý·ü 9
  • milline rate
    1milline ´çÀÇ ±¤°í·á
  • minimum lending rate
    (¿µ)(À×±Û·£µå ÀºÇàÀÇ) ÃÖÀú ´ëÃ⠱ݸ®
  • poor rate
    ±¸ºó¼¼
  • prime rate
    (¹Ì±¹ ÀºÇàÀÌ 1·ù ±â¾÷¿¡ Àû¿äÇÏ´Â)Ç¥ÁØ ±Ý¸®
  • rate
    ºñÀ²;¿ä±Ý;½Ã¼¼;°¡°Ý;Æò°¡;¼Óµµ;Áøµµ;ÇÏ·çÀÇ ¿ÀÂ÷(½Ã°èÀÇ);¼¼±Ý;Áö¹æ¼¼;µî±Þ(¹è.¼±¿øÀÇ)...µî;Á¾·ù;Æò°¡ÇÏ´Ù;¾î¸²Àâ´Ù;...À¸·Î ¾Ë´Ù;À̶ó°í »ý°¢ÇÏ´Ù;(°ú¼¼¸¦ ¸ñÀûÀ¸·Î)...À» Æò°¡ÇÏ´Ù;...¿¡°Ô Áö¹æ¼¼¸¦ °úÇÏ´Ù;(¼±¿ø.¼±¹ÚÀÇ)µî±ÞÀ» Á¤ÇÏ´Ù;±Ô°ÝÀ» Á¤ÇÏ´Ù;(±â°èÀÇ)¿ÀÂ÷¸¦ Ãø
  • rate base
    (ÀâÁöÀÇ)º¸Áõ ºÎ¼ö(À̸¦ ¹ÙÅÁÀ¸·Î ±¤°í¿ä±ÝÀÌ Á¤ÇØÁü)
  • rate card
    ±¤°í ¿äÀ²Ç¥(±¤°í ¿ä±Ý.°ÔÀç ȸ¼ö.¿ø°í ¸¶°¨ÀÏ µîÀ» ¸í½ÃÇÑ Ç¥)
  • rate meter
    (°è¼ö±âÀÇ)°è¼öÀ²°è
  • rediscount rate
    (¾îÀ½ÀÇ)ÀçÇÒÀÎÀ²
  • second rate
    2·ùÀÇ;2µîǰ;...¸¸ ¸øÇÑ
  • second rate
    2·ùÀÇ;¿­µîÇÑ;Æò¹üÇÑ
  • third rate
    3µîÀÇ;¿­µîÇÑ
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KMLE ¾àǰ/ÀǾàǰ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
KMLE ¾àǰ/ÀǾàǰ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
KMLE ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
ÀÇÇÐ³í¹® ¾àÀÚ(Pubmed/Entrez) °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
CancerWEB ¿µ¿µ ÀÇÇлçÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
MeSH(Medical Subject Headings) ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 4
MeSH(Medical Subject Headings) À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 4
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü ¸ÂÃã °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 4
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü À¯»ç °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 4
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 4
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 4
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 4
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 4
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ ¸ÂÃã °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 4
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ À¯»ç °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 4
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference ¸ÂÃã °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 4
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference À¯»ç °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 4
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition ¸ÂÃã °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 4
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition À¯»ç °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 4
KMLE À¥ ¿ë¾î ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
KMLE À¥ ¿ë¾î À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
ÇÑ¿µ/¿µÇÑ »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
WordNet ÀÏ¹Ý ¿µ¿µ »çÀü °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü ¸ÂÃã °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 4
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü À¯»ç °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 4
ÅëÇÕ°Ë»ö ¿Ï·á